Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody

Journal of Molecular Endocrinology

Volumn 46, Issue 2, 2011, Pages 81-99

  Sanders, Paul ^a   Young, Stuart ^a   Sanders, Jane ^a   Kabelis, Katarzyna ^a   Baker, Stuart ^a   Sullivan, Andrew ^a   Evans, Michele ^a   Clark, Jill ^a   Wilmot, Jane ^a   Hu, Xiaoling ^a   Roberts, Emma ^a   Powell, Michael ^a   Miguel, Ricardo Núñez ^a   Furmaniak, Jadwiga ^a   Smith, Bernard Rees ^a  

^a RSR LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AUTOANTIBODY; MONOCLONAL ANTIBODY; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CHO CELL; CRYSTAL STRUCTURE; CRYSTALLIZATION; DEGLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

AMINO ACIDS; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHO CELLS; CRICETINAE; CRICETULUS; CRYSTALLIZATION; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; MUTATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; X-RAY DIFFRACTION;

EID: 79953675359     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-10-0127     Document Type: Article

References (57)

1. Birk HW & Koepsell H 1987 Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic sites and reduction of non-specific antibody binding. Analytical Biochemistry 164 12-22. (doi:10.1016/ 0003-2697(87)90360-5)
2. Bolton J, Sanders J, Oda Y, Chapman C, Konno R, Furmaniak J & Rees Smith B 1999 Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clinical Chemistry 45 2285-2287.
3. Bork P, Sander C & Valencia A 1993 Convergent evolution of similar enzymatic function on different protein folds: the hexokinase, ribokinase and galactokinase families of sugar kinases. Protein Science 2 31-40. (doi:10.1002/pro.5560020104)
4. Chazenbalk GD, Latrofa F, McLachlan SM & Rapoport B 2004 Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of acritical conformation attheNterminus of the thyrotropin receptor A-subunit. JournalofClinical Endocrinology and Metabolism 89 1788-1793. (doi:10.1210/jc.2003-031554)
5. Chen CR, Tanaka K, Chazenbalk GD, McLachlan SM & Rapoport B 2001 A full biological response to autoantibodies in Graves' disease requires a disulfide-bond loop in the thyrotropin N-terminus homologous to a laminin EGF-like domain. Journal of Biological Chemistry 276 14767-14772. (doi:10.1074/jbc.M008001200)
6. Chen CR, McLachlan SM & Rapoport B 2010 Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation. Endocrinology 151 1940-1947. (doi:10.1210/en.2009-1430)
7. Collaborative Computational project, number 4 1994 The CCP4 Suite: Programmes for protein Crystallography. Acta Crystallographica D50 760-763.
8. Costagliola S, Bonomi M, Morganthaler NG, Van Durme J, Panneels V, Refetoff S & Vassart G 2004 Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Molecular Endocrinology 18 3020-3034. (doi:10.1210/me.2004-0231)
9. DeLano WL 2002 The Pymol molecular graphics system. DeLano Scientific, San Carlos, CA. http://pymol.sourceforge.net/.
10. Emsley P, Lohkamp B, Scott W & Cowtan K 2010 Features and developments of COOT. Acta Crystallographica D66 486-501. (doi:10.1107/S0907444910007493)
11. Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, Wilmot J, Hu X, Kabelis K, Clark J et al. 2010 Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clinical Endocrinology 73 404-412. (doi:10.1111/j.1365-2265.2010.03831.x)
12. Fan QR & Hendrickson WA 2005 Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 269-277. (doi:10.1038/nature03206)
13. Jeffreys J, Depraetere H, Sanders J, Oda Y, Evans M, Kiddie A, Richards T, Furmaniak J & Rees Smith B 2002 Characterization of the thyrotropin binding pocket. Thyroid 12 1051-1061. (doi:10. 1089/105072502321085144)
14. Jones S & Thornton JM 1996 Principles of protein-protein interactions. PNAS 93 13-20. (doi:10.1073/pnas.93.1.13)
15. Kim WB, Cho BY, Park HY, Lee HK, Kohn LD, Tahara K & Koh C 1996 Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment. Journal of Clinical Endocrinology and Metabolism 81 1758-1767. (doi:10.1210/jc.81.5.1758)
16. Kim WB, Chung HK, Lee HK, Kohn LD, Tahara K & Cho BY 1997 Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications. Journal of Clinical Endocrinology and Metabolism 82 1953-1959. (doi:10.1210/jc.82.6.1953)
17. Kleinau G, Jaeschke H, Mueller S, Raaka BM, Neumann S, Paschke R & Krause G 2008 Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor. FASEB Journal 22 2798-2808. (doi:10.1096/fj.07-104711)
18. Kosugi S, Ban T & Kohn LD 1993 Identification of thyroid antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. MolecularEndocrinology 7 114-130.(doi:10.1210/me.7.1.114)
19. Kung AWC, Lau KS & Kohn LD 2001 Epitope mapping of TSH receptor-blocking antibodies in Graves' disease that appear during pregnancy. Journal of Clinical Endocrinology and Metabolism 86 3647-3653. (doi:10.1210/jc.86.8.3647)
20. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T5. Nature 227 680-684. (doi:10.1038/ 227680a0)
21. Laskowski RA, MacArthur MW, Moss DS & Thornton JM 1993 PROCHECK-a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 26 283-291. (doi:10.1107/S0021889892009944)
22. Latif R, Morshed SA, Zaidi M & Davies TF 2009 The thyroid stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid stimulating hormone receptor antibodies on multimerisation, cleavage, and signaling. Endocrinology and Metabolism Clinics of North America 38 319-341. (doi:10.1016/j.ecl.2009.01.006)
23. Lee B & Richards FM 1971 The interpretation of protein structures: estimation of static accessibility. Journal of Molecular Biology 55 379-400. (doi:10.1016/0022-2836(71)90324-X)
24. Lo Conte L, Chothia C & Janin J 1999 The atomic structure of protein-protein recognition sites. Journal of Molecular Biology 285 2177-2198. (doi:10.1006/jmbi.1998.2439)
25. Loos U, Franz C, Minich WB & Büsselmann I 2007 Direct assay of TSH receptor autoantibodies causing Graves' disease correlates with the clinical diagnosis closer than assays based on TSH displacement. Hormone Research 68 (Supplement 3) 21-91.
26. McKenzie JM & Zakarija M 1992 Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2 155-159. (doi:10.1089/thy.1992.2.155)
27. McLachlan SM & Rapoport B 1996 Monoclonal, human autoanti-bodies to the TSH receptor-the holy grail and why are we looking for it? Journal of Clinical Endocrinology and Metabolism 81 3152-3154. (doi:10.1210/jc.81.9.3152)
28. Minich WB & Loos U 2000 Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Experimental and Clinical Endocrinology and Diabetes 108 110-119. (doi:10.1055/s-2000-5804)
29. Minich WB, Lenzner C, Bergmann A & Morgenthaler NG 2004 A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies. Journal of Clinical Endocrinology and Metabolism 89 352-356. (doi:10.1210/jc.2003-030823)
30. Mizutori Y, Chen CR, McLachan SM & Rapoport B 2008 The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Molecular Endocrinology 22 1171-1182. (doi:10.1210/ me.2007-0407)
31. Morganthaler NG, Minich WB, Willnich M, Bogusch T, Hollidt JM, Weglohner W, Lenzner C & Bergmann A 2003 Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum. Molecular and Cellular Endocrinology 212 73-79. (doi:10.1016/ j.mce.2003.09.018)
32. Morganthaler NG, Ho SC & Minich WB 2007 Stimulating and blocking thyroid stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. Journal of Clinical Endocrinology and Metabolism 92 1058-1065. (doi:10.1210/jc.2006-2213)
33. Mueller S, Kleinau G, Jaeschke H, Paschke R & Krause G 2008 Extended hormone binding site of the human thyroid stimulating hormone receptor. Journal of Biological Chemistry 283 18048-18055. (doi:10.1074/jbc.M800449200)
34. Nagayama Y, Wadsworth HL, Russo D, Chazenbalk GD & Rapoport B 1991 Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. Journal of Clinical Investigation 88 336-340. (doi:10.1172/JCI115297)
35. Nakatake N, Sanders J, Richards T, Burne P, Barrett C, Dal Pra C, Presotto F, Betterle C, Furmaniak J & Rees Smith B 2006 Estimation of serum TSH receptor autoantibody concentration and affinity. Thyroid 16 1077-1084. (doi:10.1089/thy.2006.16. 1077)
36. Núñez Miguel R, Sanders J, Chirgadze DY, Blundell TL, Furmaniak J & Rees Smith B 2008 FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity. Journal of Molecular Endocrinology 41 145-164. (doi:10.1677/JME-08-0040)
37. Núñez Miguel R, Sanders J, Chirgadze DY, Furmaniak J & Rees Smith B 2009 Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions. Journal of Molecular Endocrinology 42 381-395. (doi:10.1677/JME-08-0152)
38. Padlan EA 1990 On the nature of antibody combining sites. Unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 7 112-124. (doi:10.1002/prot. 340070203)
39. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoanti-bodies. Endocrine Reviews 19 673-716. (doi:10.1210/er.19.6.673)
40. Rees Smith B, McLachlan SM & Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocrine Reviews 9 106-121. (doi:10. 1210/edrv-9-1-106)
41. Rees Smith B, Sanders J & Furmaniak J 2007 TSH receptor antibodies. Thyroid 17 923-938. (doi:10.1089/thy.2007.0239)
42. Rees Smith B, Sanders J, Evans M, Tagami T & Furmaniak J 2009 TSH receptor-autoantibody interactions. Hormone and Metabolic Research 41 448-455. (doi:10.1055/s-0029-1220913)
43. Richmond TJ 1984 Solvent accessible surface area excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. Journal of Molecular Biology 178 63-89. (doi:10.1016/0022-2836(84)90231-6)
44. Sanders J,Oda Y, Roberts SA, Maruyama M, Furmaniak J & Rees Smith B 1997 Understanding the thyrotropin receptor function-structure relationship. Baillière's Clinical Endocrinology and Metabolism 11 451-479. (doi:10.1016/S0950-351X(97)80693-3)
45. 125I-labelled TSH receptor. Journal of Clinical Endocrinology and Metabolism 84 3797-3802. (doi:10.1210/jc.84.10.3797)
46. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J et al. 2002 Thyroid stimulating monoclonal antibodies. Thyroid 12 1043-1050. (doi:10. 1089/105072502321085135)
47. Sanders J, Evans M, Premawardhana LDKE, Depraetere H, Jeffreys J, Richards T, Furmaniak J & Rees Smith B 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362 126-128. (doi:10. 1016/S0140-6736(03)13866-4)
48. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LD, Chirgadze DY, Núñez Miguel R et al. 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14 560-570. (doi:10.1089/1050725041692918)
49. Sanders J, Allen F, Jeffreys J, Bolton J, Richards T, Depraetere H, Nakatake N, Evans M, Kiddie A, Premawardhana LDKE et al. 2005 Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 15 672-682. (doi:10.1089/thy.2005.15.672)
50. Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, Evans M, Kiddie A, Summerhayes S, Roberts E et al. 2006 Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 16 1195-1206. (doi:10. 1089/thy.2006.16.1195)
51. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M et al. 2007a Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17 395-410. (doi:10.1089/thy.2007.0034)
52. Sanders J, Núñez Miguel R, Bolton J, Bhardwaja A, Sanders P, Nakatake N, Evans M, Furmaniak J & Rees Smith B 2007b Molecular interactions between the TSH receptor and a thyroid-stimulating monoclonal autoantibody. Thyroid 17 699-706. (doi:10.1089/thy.2007.0041)
53. Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, Roberts E, Wilmot J, Richards T, Kiddie A et al. 2008 A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid 18 735-746. (doi:10.1089/thy. 2007.0327)
54. Schwarz-Lauer L, Chazenbalk GD, McLachlan SM, Ochi Y, Nagayama Y & Rapoport B 2002 Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid 12 115-120. (doi:10.1089/105072502753522347)
55. Tahara K,Ban T,Minegishi T and Kohn LD 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochemical and Biophysical Research Communications 179 70-77. (doi:10.1016/0006-291X(91)91335-A)
56. Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y & Kohn LD 1997 Epitopes for thyroid stimulating and thyroid blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid 7 867-877. (doi:10.1089/thy. 1997.7.867)
57. Thorpe IF & Brooks CL 2007 Molecular evolution of affinity and flexibility in the immune system. PNAS 104 8821-8826. (doi:10. 1073/pnas.0610064104)